Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Racial minority group interest in direct-to-consumer genetic testing: findings from the PGen study.

Landry L, Nielsen DE, Carere DA, Roberts JS, Green RC; PGen Study Group.

J Community Genet. 2017 Oct;8(4):293-301. doi: 10.1007/s12687-017-0325-5. Epub 2017 Sep 4.

2.

Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda.

Hamilton JG, Abdiwahab E, Edwards HM, Fang ML, Jdayani A, Breslau ES.

J Gen Intern Med. 2017 Mar;32(3):315-324. doi: 10.1007/s11606-016-3943-4. Epub 2016 Dec 19.

PMID:
27995427
3.

Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing.

Cragun D, Kinney AY, Pal T.

Expert Rev Mol Diagn. 2017 Jan;17(1):57-70. Epub 2016 Dec 13. Review.

PMID:
27910721
4.

Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities.

Smith CE, Fullerton SM, Dookeran KA, Hampel H, Tin A, Maruthur NM, Schisler JC, Henderson JA, Tucker KL, Ordovás JM.

Health Aff (Millwood). 2016 Aug 1;35(8):1367-73. doi: 10.1377/hlthaff.2015.1476.

5.

Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.

McCarthy AM, Bristol M, Domchek SM, Groeneveld PW, Kim Y, Motanya UN, Shea JA, Armstrong K.

J Clin Oncol. 2016 Aug 1;34(22):2610-8. doi: 10.1200/JCO.2015.66.0019. Epub 2016 May 9.

6.
7.

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.

Cragun D, Bonner D, Kim J, Akbari MR, Narod SA, Gomez-Fuego A, Garcia JD, Vadaparampil ST, Pal T.

Breast Cancer Res Treat. 2015 May;151(1):169-76. doi: 10.1007/s10549-015-3374-7. Epub 2015 Apr 14.

8.

Racial variation in frequency and phenotypes of APC and MUTYH mutations in 6,169 individuals undergoing genetic testing.

Inra JA, Steyerberg EW, Grover S, McFarland A, Syngal S, Kastrinos F.

Genet Med. 2015 Oct;17(10):815-21. doi: 10.1038/gim.2014.199. Epub 2015 Jan 15.

9.

Differences in BRCA counseling and testing practices based on ordering provider type.

Cragun D, Camperlengo L, Robinson E, Caldwell M, Kim J, Phelan C, Monteiro AN, Vadaparampil ST, Sellers TA, Pal T.

Genet Med. 2015 Jan;17(1):51-7. doi: 10.1038/gim.2014.75. Epub 2014 Jun 12.

10.

Are public health professionals prepared for public health genomics? A cross-sectional survey in Italy.

Marzuillo C, De Vito C, D'Addario M, Santini P, D'Andrea E, Boccia A, Villari P.

BMC Health Serv Res. 2014 May 28;14:239. doi: 10.1186/1472-6963-14-239.

11.

Physicians' attitudes about multiplex tumor genomic testing.

Gray SW, Hicks-Courant K, Cronin A, Rollins BJ, Weeks JC.

J Clin Oncol. 2014 May 1;32(13):1317-23. doi: 10.1200/JCO.2013.52.4298. Epub 2014 Mar 24.

12.

Family history of cancer associated with breast tumor clinicopathological features.

Ricks LJ, Ewing A, Thompson N, Harrison B, Wilson B, Richardson F, Carter-Nolan P, Spencer C, Laiyemo A, Williams C.

J Community Genet. 2014 Jul;5(3):233-40. doi: 10.1007/s12687-013-0180-y. Epub 2014 Jan 15.

13.

BRCA sequencing and large rearrangement testing in young Black women with breast cancer.

Pal T, Bonner D, Cragun D, Johnson S, Akbari M, Servais L, Narod S, Vadaparampil S.

J Community Genet. 2014 Apr;5(2):157-65. doi: 10.1007/s12687-013-0166-9. Epub 2013 Aug 29.

14.

Age at diagnosis may trump family history in driving BRCA testing in a population of breast cancer patients.

Vig HS, McCarthy AM, Liao K, Demeter MB, Fredericks T, Armstrong K.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1778-85. doi: 10.1158/1055-9965.EPI-13-0426. Epub 2013 Aug 5.

15.

Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice.

Wade CH, Tarini BA, Wilfond BS.

Annu Rev Genomics Hum Genet. 2013;14:535-55. doi: 10.1146/annurev-genom-091212-153425. Epub 2013 Jul 15. Review.

16.

Incorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physicians.

Bernhardt BA, Zayac C, Gordon ES, Wawak L, Pyeritz RE, Gollust SE.

Per Med. 2012 Sep 1;9(7):683-692.

17.

Views of internists towards uses of PGD.

Klitzman R, Chung W, Marder K, Shanmugham A, Chin LJ, Stark M, Leu CS, Appelbaum PS.

Reprod Biomed Online. 2013 Feb;26(2):142-7. doi: 10.1016/j.rbmo.2012.11.006. Epub 2012 Nov 21.

18.

Pharmacogenetics in primary care: the promise of personalized medicine and the reality of racial profiling.

Hunt LM, Kreiner MJ.

Cult Med Psychiatry. 2013 Mar;37(1):226-35. doi: 10.1007/s11013-012-9303-x.

19.

Challenges in the care for consanguineous couples: an exploratory interview study among general practitioners and midwives.

Teeuw ME, Hagelaar A, ten Kate LP, Cornel MC, Henneman L.

BMC Fam Pract. 2012 Oct 26;13:105. doi: 10.1186/1471-2296-13-105.

20.

Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and families.

Reiff M, Ross K, Mulchandani S, Propert KJ, Pyeritz RE, Spinner NB, Bernhardt BA.

Clin Genet. 2013 Jan;83(1):23-30. doi: 10.1111/cge.12004. Epub 2012 Sep 18.

Supplemental Content

Support Center